Goldplat CEO Werner Klingenberg discusses dividend policy, share buybacks and the Kilimenpesa sale. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Share News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 0.50 (4.17%)
Open: 12.25
High: 12.25
Low: 12.25
Yest. Close: 12.25
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

Tue, 6th Apr 2021 15:40

(Alliance News) - Yourgene Health PLC on Tuesday said it has signed a Covid testing services agreement with MyHealthChecked PLC to support their newly announced partnership with Boots UK Ltd.

Manchester-based molecular diagnostics firm Yourgene will partner with healthcare firm MyHealthChecked to supply its at-home nasal testing kits and laboratory testing services to Boots online and its 507 stores.

The agreement has an initial term of 12 months with Boots receiving a commission on all sales.

Yourgene is currently the exclusive provider of testing services for MyHealthChecked.

The testing kit will allow customers to take a nasal swab at home and send samples via the Royal Mail Tracked service to be tested at the laboratories of MyHealthChecked and Yourgene before online results are provided within 48 hours.

"I would like to congratulate MyHealthChecked on this agreement with Boots and we look forward to supporting their Covid-19 testing service and product supply to their laboratory," said Yourgene Chief Executive Officer & MyHealthChecked Non-Executive Director Lyn Rees.

"Covid-19 PCR tests have become a travel essential and as we anticipate the return of international travel later in the year, we expect to see an increase in demand which we are well positioned to deal with."

Shares in Yourgene were quoted at 14.50 pence in London on Tuesday afternoon, up 1.8%. The stock is down 1.7% so far in 2021.

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

IN BRIEF: Yourgene Health secures agreement for Ranger technology

IN BRIEF: Yourgene Health secures agreement for Ranger technology

21 Jun 21 21:26

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

18 Jun 21 13:23

Yourgene awarded supply contract with NHS Wales

(Sharecast News) - Molecular diagnostics group Yourgene Health has secured a contract to supply its Elucigene DPYD testing kits to NHS Wales.

18 Jun 21 09:17

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

9 Jun 21 14:09

Yourgene inks agreement with US-based precision medicine company

(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.

9 Jun 21 09:58

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

19 May 21 19:33

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

18 May 21 19:15

MyHealthChecked seals second Covid-19 test contract with Boots

MyHealthChecked seals second Covid-19 test contract with Boots

17 May 21 10:56

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

29 Apr 21 14:34

IN BRIEF: Yourgene wins two tenders for national framework contract

IN BRIEF: Yourgene wins two tenders for national framework contract

26 Apr 21 14:22

Yourgene awarded two more PHE framework agreements

(Sharecast News) - Molecular diagnostics company Yourgene announced on Monday that Public Health England (PHE) has confirmed that it was successful with its tenders under PHE's National Microbiology Framework for 'Lot 2', for research and development goods and services, and 'Lot 3', for manufacturing, product development and commercialisation.

26 Apr 21 10:56

UPDATE: Yourgene wins further national framework contract award

UPDATE: Yourgene wins further national framework contract award

19 Apr 21 14:10

Yourgene wins national contract award for Covid-19 testing services

Yourgene wins national contract award for Covid-19 testing services

19 Apr 21 11:44

Yourgene awarded PHE diagnostics framework agreement

(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.

19 Apr 21 08:49

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

6 Apr 21 15:40

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.